Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.
The broad-spectrum antiviral arbidol (Arb) inhibits cell entry of enveloped viruses by blocking viral fusion with host cell membrane. To better understand Arb mechanism of action, we investigated its interactions with phospholipids and membrane peptides. We demonstrate that Arb associates with phosp...
Enregistré dans:
Auteurs principaux: | Elodie Teissier, Giorgia Zandomeneghi, Antoine Loquet, Dimitri Lavillette, Jean-Pierre Lavergne, Roland Montserret, François-Loïc Cosset, Anja Böckmann, Beat H Meier, François Penin, Eve-Isabelle Pécheur |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b5018ec167664ed6b836c2e03b8ff3e2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
par: Jimena Perez-Vargas, et autres
Publié: (2019) -
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
par: Behnam Amani, et autres
Publié: (2021) -
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
par: Marlène Dreux, et autres
Publié: (2009) -
Unlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicity.
par: Julia Gath, et autres
Publié: (2014) -
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity.
par: Sang Ho Park, et autres
Publié: (2021)